Antihuman thymocyte globulin for prophylaxis of graft-versus-host disease. A randomized trial in patients with leukemia treated with HLA-identical sibling marrow grafts

Transplantation. 1979 Apr;27(4):227-30. doi: 10.1097/00007890-197904000-00003.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Antilymphocyte Serum / adverse effects
  • Antilymphocyte Serum / therapeutic use*
  • Blood Cell Count
  • Blood Platelets
  • Bone Marrow Transplantation
  • Child
  • Child, Preschool
  • Female
  • Graft vs Host Reaction*
  • Granulocytes
  • HLA Antigens*
  • Humans
  • Infant
  • Leukemia / mortality
  • Leukemia / therapy*
  • Male
  • Middle Aged
  • T-Lymphocytes / immunology*
  • Transplantation, Homologous

Substances

  • Antilymphocyte Serum
  • HLA Antigens